Gas6/Axl-mediated macrophage hyporesponsiveness drives severe pulmonary mucormycosis in diabetic mice
Frontiers in Cellular and Infection Microbiology · 2026
DOI: 10.3389/fcimb.2026.1939483 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Shotaro Kondo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Tokyo Medical University, Tokyo, Japan. Hauptthemen laut MEDLINE: Mucormycosis, Receptor Protein-Tyrosine Kinases, Macrophages, Intercellular Signaling Peptides and Proteins. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Pulmonary mucormycosis is a life-threatening fungal infection with a mortality rate exceeding 50%, and diabetes mellitus is one of its strongest risk factors. However, the molecular mechanisms linking diabetes to impaired pulmonary innate immunity remain poorly understood.
Methods
A streptozotocin-induced type 1 diabetes (T1D) mouse model was used to investigate host responses to intratracheal Cunninghamella bertholletiae infection. Genetic Axl deficiency, pharmacological Axl inhibition with BGB324, histopathological analyses, and ex vivo and in vitro macrophage assays were performed to define the role of the Gas6/Axl axis in antifungal immunity.
Results
T1D mice exhibited rapid mortality after pulmonary C. bertholletiae infection, accompanied by markedly impaired early neutrophil recruitment. Elevated lung and serum levels of growth arrest-specific protein 6 (Gas6) were intrinsic features of the diabetic state and correlated with blood glucose levels. Genetic ablation or pharmacological blockade of Axl restored macrophage chemokine responses, increased neutrophil recruitment into the airspace, reduced fungal burden, and significantly improved survival in T1D mice. Mechanistically, the Gas6/Axl axis directly suppressed fungus-induced chemokine production by alveolar macrophages, establishing a pre-existing state of innate immune hyporesponsiveness before infection.
Conclusions
These findings identify the Gas6/Axl axis as a mechanistic link between diabetes and impaired pulmonary innate immunity. Targeting this pathway may represent a promising host-directed therapeutic strategy for pulmonary mucormycosis in patients with diabetes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Tokyo Medical University, Tokyo, Japan.
- Department of Immunology, Nara Medical University, Nara, Japan.
Zitieren
APA
Kondo, S., Owaki, K., Hamasaki, G., Inukai, T., Kinoshita, J., Ito, T., Nakamura, S., & Shibata, T. (2026). Gas6/Axl-mediated macrophage hyporesponsiveness drives severe pulmonary mucormycosis in diabetic mice. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1939483
Vancouver
Kondo S, Owaki K, Hamasaki G, Inukai T, Kinoshita J, Ito T, et al. Gas6/Axl-mediated macrophage hyporesponsiveness drives severe pulmonary mucormycosis in diabetic mice. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1939483
BibTeX
@article{Kondo2026,
author = {Kondo, Shotaro and Owaki, Keito and Hamasaki, Gento and Inukai, Tatsuya and Kinoshita, Jotaro and Ito, Toshihiro and Nakamura, Shigeki and Shibata, Takehiko},
title = {Gas6/Axl-mediated macrophage hyporesponsiveness drives severe pulmonary mucormycosis in diabetic mice},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
doi = {10.3389/fcimb.2026.1939483}
}
EUVIMED